| http://www.w3.org/ns/prov#value | - If approved, these new therapies will create a new market.Increased Use of HSCTs for Hematologic MalignanciesHSCT is a treatment option for certain types of leukemia and lymphoma such as Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) and Myelodysplastic Syndrome (MDS) when chemotherapy and/or radiation therapy fail.
|
